COLORADO SPRINGS, Colo.,
March 13, 2015 /PRNewswire/ -- Cannabis Science, Inc. (OTCQB:
CBIS), a U.S. Company specializing in cannabis formulation-based
drug development related consulting, is please to
announce key progress with its subsidiary, Michigan Green
Technologies.
"MGT has continued to work with key legislators in Michigan to rectify the Michigan Medical
Marihuana Act of 2008. Michigan's medical cannabis program
has not seen the success in other states and if proper legislation
can be implemented then a proper cannabis economy with integrity
can begin to function, we believe we are playing a key role in this
outstanding progress. The participants will flourish under proper
legal protection that law enforcement can embrace, and the
State of Michigan and its citizens
will benefit substantially," stated John
Dalaly, CEO of Michigan Green Technologies.
Since 1987 John D Dalaly has provided hospital management
services to over 47 hospitals in ten country's that included,
staffing, education, lecturing recruiting and operations and
design of healthcare applications. John has also with
Southern Mississippi university and
MSU developed a state of the art hospital management systems
for third world countries and well as the ministry of health
in Saudi, Kuwait, Iraq, Dubai,
Amman, Muscat Oman, Mexico and Africa. John also developed from 1987 till
present the mobile medical unit's program clinic on wheels that has
provided outreach programs nationally and internationally.
John's healthcare knowledge domestically and internationally will
be used to advance the current Michigan
State initiatives enhancing economic and opportunities
within the state of Michigan.
John's political ties nationally and internationally give him the
ability to get the job done.
Working with Michigan State
legislation is the priority; MGT has actively signed several key
members from Michigan to the new
Advisory Board such as former law enforcement officers, former
legislators, medical professionals, and other strategic personnel
to help with the anticipated workload. The goal of the advisory
board is to offer a diverse range of additional resources to assist
the executive team in implementing operations in the State of
Michigan.
To learn more about Michigan Green Technologies, please see the
Company's website at the following
link: www.michigangreentechnologies.com
To learn more about Cannabis Science, please see the
Company's website and recent announcements at the following link:
www.cannabisscience.com.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding
of metabolic processes to provide novel treatment approaches to a
number of illnesses for which current treatments and understanding
remain unsatisfactory. Cannabinoids have an extensive history
dating back thousands of years, and currently, there are a growing
number of peer-reviewed scientific publications that document the
underlying biochemical pathways that cannabinoids modulate. The
Company works with leading experts in drug development, medicinal
characterization, and clinical research to develop, produce, and
commercialize novel therapeutic approaches for the treatment for
illnesses caused by infections as well as for age-related illness.
Our initial focus is on skin cancers and neurological
conditions.
Forward-Looking Statements
This Press Release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Act of 1934. A statement containing words
such as "anticipate," "seek," intend," "believe," "estimate,"
"expect," "project," "plan," or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Some or all of the events
or results anticipated by these forward-looking statements may not
occur. Factors that could cause or contribute to such differences
include the future U.S. and global economies, the impact of
competition, and the Company's reliance on existing regulations
regarding the use and development of cannabis-based drugs. Cannabis
Science, Inc., does not undertake any duty nor does it intend to
update the results of these forward-looking statements
Media Contacts:
VAN STONE PUBLICITY
Carrol Van Stone
carrol@vanstonepublicity.com
Tel: 304-671-0244
Cannabis Science, Inc.
Raymond C. Dabney
President & CEO, Co-Founder
info@cannabisscience.com
Tel: 1.888.889.0888
Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1.888.889.0888
www.cannabisscience.com
www.michigangreentechnologies.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cannabis-science-subsidiary-michigan-green-technologies-mgt-announces-key-progress-with-its-michigan-state-initiatives--a-new-advisory-board-with-significant-board-members-300050351.html
SOURCE Cannabis Science, Inc.